The prostate cancer DREAM challenge: A community-wide effort to use open clinical trial data for the quantitative prediction of outcomes in metastatic prostate cancer

Oncologist

Volumn 20, Issue 5, 2015, Pages 459-460

  Abdallah, Kald ^a   Hugh Jones, Charles ^b   Norman, Thea ^c   Friend, Stephen ^c   Stolovitzky, Gustavo ^d,e  

^a ProjectData Sphere   (United States)

^b SANOFI   (France)

^c SAGE BIONETWORKS   (United States)

^d IBM T J WATSON RESEARCH CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ALGORITHM; AMYOTROPHIC LATERAL SCLEROSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RESEARCH; CLINICAL ASSESSMENT; COMPUTER ANALYSIS; DATA PROCESSING; DISEASE COURSE; EDITORIAL; GENE SEQUENCE; HUMAN; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN STRUCTURE; CLINICAL TRIAL (TOPIC); GENETICS; MALE; METASTASIS; PATHOLOGY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84929076162     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0054     Document Type: Editorial

References (6)

1. Surowiecki J. The Wisdom of Crowds. New York, NY: Anchor Books, 2005.
2. Boutros PC, Margolin AA, Stuart JM et al. Toward betterbenchmarking:Challenge-basedmethodsassessment in cancer genomics. Genome Biol 2014;15:462.
3. Shi S, Pei J, Sadreyev RI et al. Analysis of CASP8 targets, predictions and assessment methods. Database (Oxford) 2009;bap003.
4. Brownstein CA, Beggs AH, Homer N et al. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol 2014;15:R53.
5. Jarchum I, Jones S. DREAMing of benchmarks. Nat Biotechnol 2015;33:49-50.
6. Küffner R, Zach N, Norel R et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol 2015; 33:51-57.